Skip to main content
Sunil Sharma, MD, Oncology, Scottsdale, AZ

Sunil Sharma MD

Gastrointestinal Cancer, Hematologic Oncology, Clinical Pharmacology


Virginia G Piper Distinguished Chair in Innovative Cancer Research, Director of Center for Translational Science at Honor Health Research Institute, Professor in School of Medicine and Advanced Medical Engineering, Arizona State University

Join to view full profile
  • 10510 N 92nd Street Suite 200Scottsdale, AZ 85258

  • Phone+1 480-323-1350

Dr. Sharma is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Summary

  • Dr. Sunil Sharma is an oncology specialist based in Scottsdale, AZ, with subspecialties in gastrointestinal cancer, hematologic oncology, and clinical pharmacology. He completed his residency in internal medicine at Michael Reese Hospital and Medical Center and his fellowship in hematology and medical oncology at the University of Texas Health Science Center. He has served in leadership roles such as Director of Translational Research and Drug Discovery at HonorHealth Scottsdale Shea Medical Center and as Division Chief at the Huntsman Cancer Institute. Dr. Sharma has extensive experience in colorectal and pancreatic cancer, hematologic oncology, and clinical research, contributing to publications on topics such as KRAS inhibitor resistance and RNA modification in leukemic stem cells. He has been involved in several significant clinical trials and has received CMS Meaningful Use Stage Certifications from Epic Systems Corporation.
  • Possible New Treatment for Childhood Cancer -- Stephen Lessnick, MD, PhD, and Su

    Two heads are better than one, they say-and researchers from Huntsman Cancer Institute (HCI) at the University of Utah have proved it. By combining basic scienc

    Sunil Sharma, M.B.A., M.D., FACP

    New Treatment Shows 80% Response Rate in a Phase I Clinical Trial, Becomes a "Breakthrough Therapy". Cancer is a complex disease to diagnose and treat. Cancer c

    DTRF 2016 Patient Meeting Presentation - Dr. Sunil Sharma, University of Utah, H

    Please enable JavaScript to experience Vimeo in all of its glory. Dr. Sunil Sharma speaks about a "New approach to inhibiting beta- catenin." This is Dr. Sharma

Education & Training

  • Creighton University School of Medicine-Phoenix
    Creighton University School of Medicine-PhoenixResidency, Gastroenterology, 2016 - 2022
  • University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of Medicine
    University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of MedicineFellowship, Hematology and Medical Oncology, 1995 - 1998
  • Michael Reese Hospital/University of Illinois College of Medicine at Chicago
    Michael Reese Hospital/University of Illinois College of Medicine at ChicagoResidency, Internal Medicine, 1990 - 1993
  • Delhi University College of Medical Sciences
    Delhi University College of Medical SciencesClass of 1988

Certifications & Licensure

  • AZ State Medical License
    AZ State Medical License 2017 - 2028
  • UT State Medical License
    UT State Medical License 2009 - 2028
  • CA State Medical License
    CA State Medical License 2018 - 2027
  • NV State Medical License
    NV State Medical License 2004 - 2027
  • NY State Medical License
    NY State Medical License 1998 - 2027
  • TX State Medical License
    TX State Medical License 1995 - 2027
  • GA State Medical License
    GA State Medical License 1993 - 1997
  • Medical Oncology
    American Board of Internal Medicine Medical Oncology
  • Join now to see all

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Inpatient 2014 Certified EHR Suite, Epic Systems Corporation, 2014, 2016-2017
  • CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014, 2016-2017
  • CMS Meaningful Use Stage 2 Certification EpicCare Inpatient 2014 Certified EHR Suite (with Beaker), Epic Systems Corporation, 2014, 2016-2017

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • Pre-Clinical Efficacy of Co-Treatment with KDM1A (LSD1) Inhibitor and Ruxolitinib or BET Inhibitor Against Post-MPN-sAML Blast Progenitor Cells
    Sunil Sharma, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Press Mentions

  • TGen, Ashion and HonorHealth: Organoids Can Help Pinpoint the Right Therapies for Cancer Patients
    TGen, Ashion and HonorHealth: Organoids Can Help Pinpoint the Right Therapies for Cancer PatientsJune 22nd, 2020
  • Arizona’s HonorHealth Research Institute First to Investigate Combination of Atovaquone & Azithromycin in COVID-19 Patients
    Arizona’s HonorHealth Research Institute First to Investigate Combination of Atovaquone & Azithromycin in COVID-19 PatientsMay 7th, 2020
  • 24 Pancreatic Cancer Patients Will Attend Charity Golf Event
    24 Pancreatic Cancer Patients Will Attend Charity Golf EventOctober 26th, 2019

Other Languages

  • Hindi

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: